Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Rating of "Hold" from Analysts

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has been assigned an average recommendation of "Hold" from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $16.67.

Several research firms have commented on MD. UBS Group cut their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Macquarie boosted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Finally, Truist Financial dropped their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th.

Pediatrix Medical Group Trading Up 1.0%

MD opened at $13.36 on Tuesday. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $17.67. The company has a market cap of $1.15 billion, a P/E ratio of -13.22, a PEG ratio of 0.89 and a beta of 1.27. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81. The business's 50-day simple moving average is $13.66 and its 200-day simple moving average is $13.92.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business's revenue for the quarter was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.20 EPS. As a group, equities research analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Pediatrix Medical Group by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock valued at $141,861,000 after purchasing an additional 113,976 shares during the last quarter. Boston Partners boosted its holdings in Pediatrix Medical Group by 1.3% in the first quarter. Boston Partners now owns 1,981,889 shares of the company's stock valued at $27,990,000 after purchasing an additional 25,536 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Pediatrix Medical Group by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock valued at $25,562,000 after purchasing an additional 11,045 shares during the last quarter. American Century Companies Inc. boosted its holdings in Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock valued at $22,820,000 after purchasing an additional 1,500,485 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Pediatrix Medical Group by 18.0% in the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company's stock valued at $12,678,000 after purchasing an additional 147,522 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.